Quick Links

 Richard Jove, Ph.D.

  • Director, Beckman Research Institute
  • Deputy Director for Basic Research, Comprehensive Cancer Center
  • Morgan and Helen Chu Director’s Chair, Beckman Research Institute
  • Professor, Molecular Medicine
  • Member, Developmental Cancer Therapeutics Program, Comprehensive Cancer Center

Professional Experience

2008 - present, Director, Beckman Research Institute of City of Hope, Duarte, CA

2005 - 2009, Co-leader, Developmental Cancer Therapeutics Program, City of Hope Comprehensive Cancer Center

2005 - present, Deputy Director, City of Hope Comprehensive Cancer Center

2005 - present, Professor, Department of Molecular Medicine, Beckman Research Institute

2005 - 2008, Chair, Department of Molecular Medicine, Beckman Research Institute

2003 - 2005, Associate Director for Basic Research, Moffitt Research Institute

2000 - 2005, Professor, Department of Interdisciplinary Oncology, University of South Florida College of Medicine

1995 - 2005, Professor, Department of Pathology, University of South Florida College of Medicine

1995 - 2005, Professor (tenured), Dept. of Biochemistry & Molecular Biology, University of South Florida

1995 - 2005, Program Leader, Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute

1994 - 1995, Associate Professor (tenured), Department of Microbiology & Immunology, University of Michigan

1992 - 1995, Director, Molecular Oncology Program, University of Michigan Comprehensive Cancer Center

1988 - 1994, Assistant Professor, Department of Microbiology and Immunology, University of Michigan

1984 - 1988, Postdoctoral Fellow, Laboratory of Viral Oncology, Rockefeller University (Dr. H. Hanafusa)

1979 - 1984, Predoctoral Fellow, Department of Biological Sciences, Columbia University (Dr. James L. Manley)

Education and Training

1984 - 1988, Rockefeller University, New York, NY. Postdoc, Viral Oncology

1984, Columbia University, New York, NY. Ph.D., Molecular Biology

1977 - 1978, State University of New York, Buffalo, NY. B.A./M.S., Cell and Molecular Biology


This is an abbreviated document. Full CV available upon request. Information on this page may be self-reported. Last updated 08/09.

Richard Jove, Ph.D.

Honors and Awards

2010, Morgan and Helen Chu Director’s Chair, Beckman Research Institute

2003 - 2005, Frank and Carol Morsani Chair in Molecular Oncology, Moffitt Cancer Center and Research Institute.

2003 - present, Scientific Advisory Boards:  Burnham Institute Cancer Center; Penn State Cancer Center; Foundation for Advanced Cancer Studies; Wyeth Research; Bristol-Myers Squibb; Pediatric Cancer Foundation; Rhode Island Hospital.

2003, Co-organizer, Annual Meeting on Oncogenes, Frederick, MD.

2002, Scientist of the Year Award, Moffitt Cancer Center and Research Institute.

2000, Guest Editor, Oncogene Reviews (STAT Signaling).

1998 - 2005, AACR Program Committees:  Molecular Biology, Cell and Tumor Biology, New Molecular Targets.

1995 - present, Ad Hoc Reviewer: NIH Virology Study Section, NCI Subcommittee A (Cancer Centers), NCI Subcommittee C (Basic and Preclinical), various NCI Site Visit Teams.

1988 - 1991, Junior Faculty Research Award, American Cancer Society

1984 - 1987, Damon Runyon-Walter Winchell Cancer Fund Postdoctoral Fellowship.

1984, John S. Newberry Prize in Biology (Outstanding Graduate Student Award), Columbia University.

 Search

Go!
Advanced Search Options
News & Publications Search

 Contact Information

To request expert commentary on, biology, immunotherapy, molecular medicine or targeted therapeutics, contact Media Relations.

To reach me or my staff,
call 626-256-HOPE (4673).

 Learn More

NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.